Increased Mortality in Connective Tissue Diseases, Primary Systemic Vasculitides
Mortality rates were higher in patients with systemic connective tissue diseases and primary systemic vasculitides.
Mortality rates were higher in patients with systemic connective tissue diseases and primary systemic vasculitides.
Patients who have been chronically exposed to hydroxychloroquine/chloroquine were not at increased risk for Alzheimer disease.
Muscle magnetic resonance imaging may complement a physician’s objective assessment in juvenile dermatomyositis, although negative MRI findings should not preclude treatment continuation.
A better understanding of the natural progression of this disease would allow earlier detection in children at high risk for functional decline.
Researchers used registry data to evaluate the risk of autoimmune diseases over 6.5 years after exposure to HPV vaccines in adolescent and young adult women.
Post hoc study subgroup analysis shows combination ambrisentan plus tadalafil therapy improves treatment response in patients with connective tissue disease-associated pulmonary arterial hypertension.
Data from a population-based case control study found that systemic glucocorticoid use was associated with increased risk of S. aureus bacteremia (CA-SAB), with a clear dose-response relationship.
Inflammatory ganglionopathies can be associated with good clinical outcomes if treatments are administered in a timely manner.
Regression of skin fibrosis is a feature of the natural history of dcSSc. However, the pattern of regression can be quite heterogeneous despite improvements in predicting progression.
CTD is associated with higher prevalence of atherosclerotic cardiovascular disease in African Americans and in young adults.